<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We assessed 33 lymphoid tissues from 15 patients, including 7 with <z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> (XLP) and 8 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1264624" disease_type="Disease or Syndrome" abbrv="">fatal infectious mononucleosis</z:e> (IM), to determine whether the cellular infiltrate had the immunophenotype and expressed Epstein-Barr virus (EBV)-encoded proteins characteristic of either EBV-immortalized lymphoblastoid cell lines (LCL) or EBV-carrying Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells </plain></SENT>
<SENT sid="1" pm="."><plain>The results of these studies revealed that in 13 cases the proliferating B cells were polyclonal, LCL-like, and in 2 cases they were monoclonal, malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-like </plain></SENT>
</text></document>